Abiopharma

🔍 Conkling Lori A (Executive)

Company: Interactive Brokers Group, Inc. (IBKR)

Report Date: 2026-02-25

Detailed Transactions and Holdings:

• Acquired 50 shares of Class A common stock at $73.21 per share (Direct)
  Date: 2026-02-25 | Code: P | equity_swap_involved: false | shares_owned_after: 2,384.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 25 shares of Class A common stock at $69.21 per share (Direct)
  Date: 2026-03-02 | Code: P | equity_swap_involved: false | shares_owned_after: 2,409.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This amount includes (a) securities acquired by the Reporting Person; (b) Class A common stock attributable to vested restricted stock units that were awarded under the 2007 Stock Incentive Plan as amended ("Plan"); and (c) unvested restricted stock units that were awarded under the Plan.
• REMARKS: The Reporting Person is hereby disclosing delinquent transactions reportable on Form 4 that were not reported due to an inadvertent oversight. These shares were purchased pursuant to a 10b5-1 trading plan.